普瑞默生物科技股份有限公司(以下簡稱普瑞默生技)今宣布，繼2022年底榮獲台北市研發補助之後，2023年與國家…
Comparing the Detection Performance Between Multiparame…
Compare the Effective dose and convenience of clinical …
Comparison of the Detection Performance Between FAP and…
作者：何秉穎 博士(普瑞默轉譯技術長) 推動一款全新藥物進入市場，動輒需耗時十年以上之光景，所投入的研發經費亦…
Compared with the difference in detection performance b…
Comparison of the effective dose and convenience of cli…
Taiwan Radiopharmaceutical Development: A Step-by-Step …
The Detection Performance of 18F–Prostate-Specific Memb…
